15PSILON 2016 PSI banner v3

The theme of the 2016 Conference was “Promoting Statistical Insight and Collaboration in Drug Development”.

Regarded as the principal annual event for statisticians in the pharmaceutical and healthcare industry in Europe, the 2016 PSI conference took place at The Pullman Hotel, Berlin, between 22 to 25 May 2016. It was the 39th consecutive annual event.

The conference will consist of a variety of plenary sessions, parallel sessions, breakout discussion sessions, a poster session and the annual general meeting.  Sessions will include an update on estimands, subgroups, dose exposure modelling, decision criteria, use of biomarkers in translational activities, clinical registries and many more with speakers from industry, academia and regulatory agencies.

2016 PSI Conference Photos 

Please click here to view the conference photos

2016 PSI Conference Slides and Recordings

Please click here to see the slides and recordings


The abstract deadline has now passed. The accepted abstracts can be found within the event app. Please click here to view the Abstract Book.

Conference App

Thank you to Astra Zeneca for their kind sponsorship of the app. The app contains the conference programme, abstracts, profiles of speakers and exhibitors.
We would encourage all delegates to download the app and create their own profile. Setting up your own profile allows you to add comments and interact with colleagues within the activity stream.
Please download the app at the following links:
Google: https://play.google.com/store/apps/details?id=com.attendify.confbfmd91 
Apple: https://itunes.apple.com/app/id1085508034 
Mobile Web Browser: http://conferenceapp2016.psiweb.org/ 

Technical Manual

Please click here to view the Exhibition Technical Manual

Scientific Programme

The scientific programme can be viewed here here. Please note the times and sessions are provisional and are subject to change.
A downloadable PDF can be viewed here.

Pre-Conference Course

A PSI Pre-Conference Training Course on Subgroup Analysis
Presented by Aaron Dane, Armin Koch, Ilya Lipkovich & Gerd Rosenkranz.  

PSI are delighted to announce the following two keynote speakers who are confirmed for our 2016 Conference:

Paul Wicks photo

Dr Paul Wicks, Vice President of Innovation at PatientsLikeMe

PatientsLikeMe is an online community for people living with medical conditions. Specialising in the conduct of clinical research using the Internet, Paul is responsible for shaping the scientific validity of the PatientsLikeMe platform and generating insights from personal health data shared by members. This sharing of online medical data has lead to over 60 studies including a patient-led observational trial of lithium in ALS, digital tools to develop patient-reported outcome measures, a “dose-response” curve for the benefits of friendship between patients, and methods for patient-centered clinical trial design. In 2011 he was awarded MIT Technology Review’s TR35 “Humanitarian of the Year” award and was recognized as a TED Fellow in 2012.


Prof. Dr. med. Stefan Lange
, Deputy Director at IQWiG

The Institute for Quality and Efficiency in Healthcare (IQWiG) is the German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions, diagnostic and screening methods, and treatment and disease management. Stefan has held the position of Deputy Director of the Institute since 2005, having joined in 2004.

Stefan completed his medical studies at the Heinrich-Heine-University in Düsseldorf in 1989 and received his MD in 1994. He was awarded the certificate of Biometrics in Medicine with the title of “Qualified Statistician” by the German Association for Medical Computer Sciences, Biometry and Epidemiology (GMDS) in 1999. In 2003 he received his PhD at the Ruhr University and received the venia legendi (right to teach) in Medical Biometry and Clinical Epidemiology.

Latest News

  • Regulatory Committee Update on Coronavirus disease (COVID-19)

    As you all know, statisticians across the globe and across industry are actively involved in trying to understand and address the impact of COVID-19 on pharmaceutical development, including the safety of the patients in our trials and the integrity and interpretability of the data we collect.
  • Quarterly Update from the PSI Chair - Q1 2020

    Welcome to the first Chair's update of 2020 and even as a statistician, I would not have been able to predict we would all be in the situation we are in today, during my last blog.
Show all news

EventsFuture Events

  • PSI ToxSIG Webinar: Good statistical practices to tackle the lack of reproducibility in preclinical research - Dates: 15 – 15 Jul, 2020

    In this webinar we will explain the how to understand the sequences of issues and how to fix it in order to drastically improve the replicability of the results. Through example the presentation will cover concepts such as OFAT vs DoE, p-values and Bayesian statistics and Power vs Assurance as easy opportunities to improve robustness of decisions.
  • PSI Toxicology SIG Workshop - Dates: 24 – 25 Nov, 2020

    PSI Toxicology SIG workshop – 24th and 25th November 2020 The Toxicology SIG provides a forum for statisticians working in regulatory/investigative toxicology, as well as most other pre-clinical areas, to discuss issues and interact with one another. This 1.5-day workshop will involve approximately 20 statisticians, focusing on discussions around “best practice” in the statistical analysis of various data types. The afternoon of Day 1 will include a 4.5 hour Bayesian training course focused towards applications in toxicology/pre-clinical, provided by Prof. Dr. Katja Ickstadt and is included in the workshop fee. The cost will be £270 including VAT per delegate, inclusive of food and one night’s accommodation (and the training course). The workshop is being held at the Crowne Plaza Hotel, Heathrow. The agenda and topics that will be discussed are yet to be finalised, but please get in touch with gareth.thomas@covance.com if you have suggestions. Full details will be circulated in the coming weeks.

Statisticians - All Levels



Expert in Clinical Trial Methodology



Clinical Statistics - Statistician/Principal Statistician



Head - Medical Market Access Statistics



Clinical Statistics Leader



Senior/Lead Biostatistician



Senior Manager Biostatistics



Manager Biostatistics


Parexel logo cropped

Senior/Principal Biostatistician